Detalhe da pesquisa
1.
T-bet deficiency attenuates cardiac remodelling in rats.
Basic Res Cardiol
; 113(3): 19, 2018 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564567
2.
Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy.
J Cell Biochem
; 118(11): 3899-3910, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390176
3.
Evodiamine attenuates TGF-ß1-induced fibroblast activation and endothelial to mesenchymal transition.
Mol Cell Biochem
; 430(1-2): 81-90, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303407
4.
Evodiamine Prevents Isoproterenol-Induced Cardiac Fibrosis by Regulating Endothelial-to-Mesenchymal Transition.
Planta Med
; 83(9): 761-769, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28010025
5.
Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition.
Biochim Biophys Acta
; 1852(11): 2456-66, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26300483
6.
OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells.
Clin Sci (Lond)
; 130(22): 2061-2071, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27580926
7.
Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.
Mol Cell Biochem
; 417(1-2): 87-96, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160937
8.
Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
Am J Physiol Heart Circ Physiol
; 308(9): H1143-54, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25713304
9.
Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
Mol Cell Biochem
; 409(1-2): 145-54, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26215454
10.
Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
J Cell Biochem
; 114(5): 1058-65, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225340
11.
NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload.
Lab Invest
; 93(10): 1128-36, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23958879
12.
Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy.
Basic Res Cardiol
; 108(2): 326, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307144
13.
HSP75 protects against cardiac hypertrophy and fibrosis.
J Cell Biochem
; 112(7): 1787-94, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21381076
14.
Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway.
Front Pharmacol
; 12: 648688, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34054527
15.
Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways.
J Cell Physiol
; 223(3): 713-26, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20175116
16.
Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
J Cell Biochem
; 109(6): 1158-71, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20127712
17.
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
J Cell Biochem
; 110(5): 1111-22, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564207
18.
Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation.
Oxid Med Cell Longev
; 2020: 2647807, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32908628
19.
Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
J Mol Med (Berl)
; 98(5): 691-705, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32280997
20.
Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
J Cell Mol Med
; 13(5): 909-25, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19413885